Yuhan Corporation, Boehringer Ingelheim Korea Launch World Diabetes Day Campaign

Joined the Korean Diabetes Association's "Blue Tree Campaign"

Yuhan Corporation and Boehringer Ingelheim Korea announced on the 12th that they had run a month-long campaign starting last month to mark World Diabetes Day, which falls on the 14th, highlighting the importance of early diabetes management and supporting patients in living healthy, fulfilling lives.

World Diabetes Day is observed every year on November 14. Activities are held around the world to raise awareness of diabetes and highlight the importance of its prevention and management.

Yuhan Corporation and Boehringer Ingelheim Korea ran a month-long campaign starting last month to mark World Diabetes Day on November 14, highlighting the importance of early diabetes management and encouraging patients to lead healthy everyday lives. Yuhan Corporation

The event was organized in connection with Boehringer Ingelheim Korea's "Dang-Jang Campaign" and jointly carried out by the two companies to raise awareness of the importance of integrated diabetes, heart and kidney care.

The two companies joined the "Blue Tree Campaign," organized by the Korean Diabetes Association, and shared the message that people should look after their heart and kidney health as well as their blood sugar. Ahead of World Diabetes Day, employees spent a month writing messages of support and encouragement for patients and hanging them on a tree to complete the Blue Tree.

Decorated with blue, star-shaped messages symbolizing a brighter daily life for people with diabetes, the Blue Tree conveyed the companies' commitment to helping patients manage their condition and continue living healthy lives.

Yoo Jaecheon, vice president of Yuhan Corporation's Pharmaceutical Business Division, said, "Building on the trust and cooperation the two companies have developed, we will continue our efforts to help improve the health of people with diabetes."

Hwang Inhwa, executive director of the CRM Business Division at Boehringer Ingelheim Korea, said, "Drawing on our expertise and leadership in diabetes, heart and kidney care, Boehringer Ingelheim Korea will continue to promote the value of integrated care that considers heart and kidney health as well as blood sugar, and to work toward improving patients' lives."

This content was produced with the assistance of AI translation services.